Intended for healthcare professionals

Research News

Antiplatelet agents for adults with chronic kidney disease?

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1392 (Published 06 March 2013) Cite this as: BMJ 2013;346:f1392

OpenUrlPubMed

Antiplatelet agents do not prevent deaths from cardiovascular disease or any other cause in adults with chronic kidney disease. In the first comprehensive meta-analysis in this patient group, drugs such as aspirin and clopidogrel reduced the risk of …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription